All Type of News
Shinpoong's anti-malaria drug to launch phase II studies.
Shinpoong announced on July 8 that they conducted a phase II study (a test for effective dose determination) for an anti-malaria drug under the Shipoong's MMV (medicines for malaria venture) project in Thailand, Ugand...
Korea to enter the age society from 2018
The Korean population for the aged of 65 years or older reached 7% in 2000, and estimated to 14% or more in 2018, indicating the nation to enter the aged society.
In 2026 the rate will surpass 20%, showing a popul...
KMA to blame pharmacist's illegal dispensing.
In the 14th medical forum conference at the KMA auditorium on July 9 on the subject of "Assessment of the Medical and Pharmacy Role Separation Program after 5 year in Practice" the KMA's medical policy research instit...
Novartis to move "Clean Summer" campaign for Lamisil
Novartis has launched a promotional campaign called "Clean Summer" for Lamisil, an athlete foot drug, for the treatment of summer athlete foot infected in toe and finger nails during July.
The campaign initially m...
Total 59,802 employees from 802 pharmaceutical manufacturers.
As of the end of 2004 the total 802 pharmaceutical manufacturers of Korea had 59,802 employees including 11,325 office workers (18.9%), 21,092 salesmen (35.27%), 5,230 research workers (8.75%) and 19,620 production wo...
Health functional foods sold 44.6% up in May via On-Line.
The National Statistical Office reported that the total on-line sales of the health functional foods and other general foods in May amounted to 42.6 billion won, which was 13 billion won more than May last year and 3....
NHI coverage extended to Visudyne, a macular degeneration therpay.Novartis Korea's Visudyne (verteporfin), a photodynamic therapeutic drug for macular degeneration, took the government approval for the NHI coverage effective from July 1, 2005 ...
|
Schering Plough to launch market promotion for anticancer and BT drugs.
Schering Plough Korea launched their own marketing activities for anti-cancer and biotech drugs as of July 1, 2005. However, Schering will keep going their other prescription drug business for Claritin (Loratadine: an...
OTC drug productions ever dwindling.
The production of OTC (non-prescription) drugs showed ever declining trend during the past 15 years according to the KPMA's production statistics.
The production ratio of the non-prescription vs. prescription drugs...
Han All to change its CI.In the 32th anniversary occasion, Han All pharmaceutical company announced to change the company image (CI), illustrating the company challenge spirits as a company specialized ...
|
